Filiz Çay Şenler

7PUBLICATIONS
56CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markersCellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2026
Immunotherapy expectations and knowledge in practice and clinical trials: a cross-sectional study.

Beliz Bahar Karaoğlan, Filiz Çay Şenler

|Jul 04, 2025
Turkish medical oncologists' perspectives on integrating artificial intelligence: knowledge, attitudes, and ethical considerations.

Efe Cem Erdat, Filiz Çay Şenler

|Mar 26, 2025
Assessing the accuracy of the GPT-4 model in multidisciplinary tumor board decision prediction.

Efe Cem Erdat, Merih Yalçıner, Mehmet Berk Örüncü

|Jul 17, 2024
Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors.

Beliz Bahar Karaoğlan, Emre Yekedüz, Satı Coşkun Yazgan

|Feb 04, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin

|Sep 01, 2020
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).

Ali Alkan, Arzu Yaşar, Zeynep Gülsüm Güç

Pageof 2

Frequent Collaborators

2 joint publications

Ali Alkan

2 joint publications

Elif Berna Köksoy

2 joint publications

Serdar Turhal

2 joint publications

Atakan Demir